Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Acetylglucosamine

Acetylglucosamine

pharmaceutical raw materials
Acetylglucosamine structure

Acetylglucosamine 

structure
  • CAS No:

    7512-17-6

  • Formula:

    C8H15NO6

  • Chemical Name:

    Acetylglucosamine

  • Synonyms:

    D-Glucose,2-(acetylamino)-2-deoxy-;D-Glucose,2-acetamido-2-deoxy-;2-(Acetylamino)-2-deoxy-D-glucose;N-Acetyl-D-glucosamine;2-Acetamido-2-deoxy-D-glucose;Acetylglucosamine;N-Acetylglucosamine;N-Acetyl-2-amino-2-deoxy-D-glucose;N-Acetyl-2-amino-2-deoxyglucose;2-Acetamido-D-glucose;2-Acetamido-2-deoxyglucose;D-N-Acetylglucosamine;Marine Sweet;NSC 524344;Bio-NAG;GreenNAG;Marine Sweet YSK;MarineSweet F;98632-70-3;134-61-2;7132-76-5;173382-53-1;948887-87-4

  • Categories:

    Biochemical Engineering  >  Saccharides

Description

N-Acetyl-D-Glucosamine is a monosaccharide derivative of glucose.


Aldehydo-N-acetyl-D-glucosamine is the open-chain form of N-acetyl-D-glucosamine. It has a role as a human metabolite.|The N-acetyl derivative of glucosamine.

Acetylglucosamine Basic Attributes

221.21

221.21

1727589

231-368-2

V956696549

DTXSID10856111

29329985

Characteristics

119

-2.1

white to off-white saline suspension

1.54 g/cm3

205 °C

636.4°C at 760 mmHg

313.9±30.1 °C

1.576

soluble in concentrated hydrochloric acid, sulfuric acid, phosphoric acid and formic acid. Insoluble in water, dilute acids, dilute alkalis, concentrated alkalis and organic solvents.H2o: 50 mg/mL colorless to faint yellow solution, clear to very slightly hazy

2-8°C

7.12E-19mmHg at 25°C

42 º (c=2,water,2 hrs)

Safety Information

NONH for all modes of transport

3

36/37/38

24/25-36-26-22

LZ6651000

Xi

Irritant

Stable. Incompatible with strong oxidizing agents.

Toxicity

Mouse, intravenous LD50 is 4170 mg/kg. Side effects that have been reported are mainly mild gastrointestinal complaints such as heartburn, epigastric distress and diarrhea. No allergic reactions have been reported including sulfa-allergic reactions to glucosamine sulfate.

Drug Information

For the treatment and prevention of osteoarthritis, by itself or in combination with chondroitin sulfate.

Approximately 90% of orally administered glucosamine (salt form) gets absorbed from the small intestine.

A significant fraction of ingested glucosamine is catabolized by first-pass metabolism in the liver.

The mechanism of action in relieving arthritic pain and in repair of cartilage is a matter of speculation. Biochemically, glucosamine is involved in glycoprotein metabolism. Glycoproteins, known as proteoglycans, form the ground substance in the extra-cellular matrix of connective tissue. Proteoglycans are polyanionic substances of high-molecular weight and contain many different types of heteropolysaccharide side-chains covalently linked to a polypeptide-chain backbone. These polysaccharides make up to 95% of the proteoglycan structure. In fact, chemically, proteoglycans resemble polysaccharides more than they do proteins. The polysaccharide groups in proteoglycans are called glycosaminoglycans (GAGs). GAGs include hyaluronic acid, chondroitin sulfate, dermatan sulfate, keratan sulfate, heparin and heparan sulfate. All of the GAGs contain derivatives of glucosamine or galactosamine. Glucosamine derivatives are found in hyaluronic acid, keratan sulfate and heparan sulfate. Chondroitin sulfate contains derivatives of galactosamine. The glucosamine-containing glycosaminoglycan hyaluronic acid is vital for the function of articular cartilage. GAG chains are fundamental components of aggrecan found in articular cartilage. Aggrecan confers upon articular cartilage shock-absorbing properties. It does this by providing cartilage with a swelling pressure that is restrained by the tensile forces of collagen fibers. This balance confers upon articular cartilage the deformable resilience vital to its function. In the early stages of degenerative joint disease, aggrecan biosynthesis is increased. However, in later stages, aggrecan synthesis is decreased, leading eventually to the loss of cartilage resiliency and to most of the symptoms that accompany osteoarthritis. During the progression of osteoarthritis, exogenous glucosamine may have a beneficial role. It is known that, in vitro, chondrocytes do synthesize more aggregan when the culture medium is supplemented with glucosamine. N-acetylglucosamine is found to be less effective in these in vitro studies. Glucosamine has also been found to have antioxidant activity and to be beneficial in animal models of experimental arthritis. The counter anion of the glucosamine salt (i.e. chloride or sulfate) is unlikely to play any role in the action or pharmacokinetics of glucosamine. Further, the sulfate in glucosamine sulfate supplements should not be confused with the glucosamine sulfate found in such GAGs as keratan sulfate and heparan sulfate. In the case of the supplement, sulfate is the anion of the salt. In the case of the above GAGs, sulfate is present as an ester. Also, there is no glucosamine sulfate in chondroitin sulfate (source: PDRhealth).

2 Acetamido 2 Deoxy D Glucose

Acetylglucosamine Use and Manufacturing

Uses

N-acetyl-D-Glucosamine (GlcNAc) is a monosaccharide derivative of glucose. It is released by the action of O-GlcNAcase, in mammalian systems from proteins that have been post-translationally modified with O-GlcNAc. Levels of O-GlcNAcylation proteins from Alzheimer’s disease brain extracts are decreased as compared to that in controls, suggesting that release of GlcNAc may contribute to pathogenesis. In E. coli, GlcNAc induces the expression of multidrug exporter genes, indicating that this sugar can alter gene expression. GlcNAc is also the monomeric unit of chitin, which is found in fungi and many invertebrates, including crustaceans, insects, and nematodes. For this reason, chemicals that inhibit the incorporation of GlcNAc into chitin are cytotoxic to these organisms.

D-Glucose, 2-(acetylamino)-2-deoxy-: ACTIVE

Computed Properties

Molecular Weight:221.21
XLogP3:-3.4
Hydrogen Bond Donor Count:5
Hydrogen Bond Acceptor Count:6
Rotatable Bond Count:6
Exact Mass:221.08993720
Monoisotopic Mass:221.08993720
Topological Polar Surface Area:127
Heavy Atom Count:15
Complexity:221
Defined Atom Stereocenter Count:4
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Drug Function and Efficacy

Supports skin barrier function and hydration; has mild exfoliating properties and promotes glycosaminoglycan synthesis for improved skin texture.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • ZHEJIANG GOLDEN-SHELL PHARMACEUTICAL CO LTD

    United States United States
    Active
  • NIPPON PROTEIN CO LTD

    United States United States
    Inactive
  • PFANSTIEHL LABORATORIES INC

    United States United States
    Inactive

Recommended Suppliers of Acetylglucosamine

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.